Photocure to present at European Biotech Investor Day 2019 in New York

Oslo, Norway, August 1, 2019 - Photocure ASA (OSE: PHO) management is conducting investor meetings in New York (US) on August 1, 2019, in connection with the European Biotech Investor Day, organized by Solebury Trout and sponsored by Goodwin LLC, Deutsche Bank, H.C. Wainwright and Nasdaq.

Please find the presentation here.

Company contact:

Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000
Email:
ed@photocure.no 

About the European Biotech Investor Day 

The European Biotech Investor Day in NYC, features privately-held and EU-listed biotechnology companies representing the “Next Wave of Opportunities” emerging from Europe.

About Photocure ASA 

Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com.